KURA ONCOLOGY, INC. (KURA) Return on equity 2023–2025
KURA ONCOLOGY, INC. (KURA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-160.0%FY2025 · since FY2023: -38.4% → -160.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -160.0% | -118.0 pp |
| FY2024 | -42.1% | -3.6 pp |
| FY2023 | -38.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More KURA financial trends
KURA RevenueKURA Net incomeKURA Net marginKURA Gross profitKURA Gross marginKURA Operating incomeKURA Operating marginKURA Operating cash flowKURA Free cash flowKURA Capital expendituresKURA Stock buybacksKURA Dividends paidKURA Total assetsKURA Total liabilitiesKURA Shareholders’ equityKURA overview →